Defymed
Latest round
- Series A
Last raised
- Nov 2013
Total raised
- $1.6M
Investors
- 1
About Defymed
Defymed specializes in creating advanced drug delivery systems designed to improve the treatment of chronic diseases. The company is headquartered in Strasbourg, France, and was acquired by Capital Grand Est in October 2015.Defymed focuses on innovative medical devices and drug delivery systems aimed at enhancing patient care in chronic disease management.9 for the same year.Defymed aims to expand its product line with new drug delivery solutions set to launch in the upcoming years. The company is targeting expansion into additional European markets and possibly North America by 2025.
Who invested in Defymed
1 investor across 1 round
See all investors in Defymed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 5, 2013
Amount
$1.6M
Investors
Questions about Defymed
Who invested in Defymed?
Defymed has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Defymed raised?
Defymed has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Defymed last raise money?
Defymed's most recent round on record is a Series A, in Nov 2013.
What does Defymed do?
Defymed specializes in creating advanced drug delivery systems designed to improve the treatment of chronic diseases.
Where is Defymed headquartered?
Defymed is headquartered in Strasbourg, France.
Which VCs invest in companies like Defymed?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at Defymed's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Defymed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.